600211 fundamentals
An in-depth look to TIBET RHODIOLA PHARMACEUTICAL HOLDING CO. operating, investing, and financing activities
600211 free cash flow for Q1 24 is 438.69 M CNY. For 2023, 600211 free cash flow was 1.06 B CNY and operating cash flow was 1.08 B CNY.
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: CNY
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM